African American Cancer Clinical Trial Decisions: Testing Tailored Messages

Completed · Not applicable

Conditions studied: Myeloma, Lymphoma, Leukemia

In brief

The purpose of this study is to determine if the use of tailored health messages and/or involving physicians are effective in increasing African American (AA) patient activation in a clinical trial consultation. The proposal will use a composite score for patient activation derived from the Street Patient Activation Coding system. This will help to determine the effectiveness of our intervention on patient activation and patient centered clinical trial decision.

Key facts

Study ID

NCT02356549

Run by

Virginia Commonwealth University

People needed

90

Starts

2015-05-01

Expected to finish

2020-03-06

Last updated by the study team

2020-04-01

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 21 years of age or older
• Have a cancer diagnosis
• Self identify as African American
• Therapeutic Phase I, II or III clinical trial at Massey Cancer Center (regardless of whether or not they join the therapeutic trial)
• Be able to provide informed consent
• We will also recruit one family member/caregiver (N = 357) of each participating patient
• Consented patients will not be excluded from this study if their family member declines to participate by completing the Cancer Communication Assessment Tool for Families (CCAT-F).
• Exclusions Criteria:
• None

Where it is running

• Virginia Commonwealth University/Massey Cancer Center — Richmond, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.